PCDHGC3 and central nervous system cancer: A TCGA database-based Kaplan–Meier analysis comparing “low” and “high” PCDHGC3 mRNA expressing gliomas, as separated by the median expression, revealed no significant correlation of PCDHGC3 expression and patients’ survival (p = 0.43).